docosanol(redirected from Abreva)
an antiviral agent effective against activity viruses with a lipid envelope, including herpes simplex virus; used topically in the treatment of recurrent herpes labialis.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.
Pregnancy Category: B
Treatment of recurrent oral-facial herpes simplex (cold sores, fever blisters).
Prevents herpes simplex virus from entering cells by preventing viral particles from fusing with cell membranes.
Reduced healing time.
Decreased duration of symptoms (pain, burning, itching, tingling).
Metabolism and Excretion: Unknown.
Contraindicated in: Hypersensitivity to docosanol or any other components of the formulation (benzyl alcohol, mineral oil, propylene glycol, or sucrose).
Use Cautiously in: Children <12 yr (safety not established);Pregnancy (use only if clearly needed).
Adverse Reactions/Side EffectsAll local reactions occured at site of application
Drug-Drug interactionNone significant.
Topical (Adults and Children ≥12 yr) Apply small amount 5 times daily to sores on lips or face until healed.
Cream: 10% cream in 2 g tubesOTC
- Assess skin lesions prior to and periodically throughout therapy.
Potential Nursing DiagnosesImpaired skin integrity, impaired (Indications)
Risk for infection, high risk for (Indications)
Deficient knowledge, related to disease process and medication regimen (Patient/Family Teaching)
- Topical: Cream should be applied to lesions 5 times daily starting at the first sign of a sore or blister.
- Instruct patient on correct technique for application of docosanol. Cream should only be applied to lips and face. Avoid application in or near eyes. Emphasize handwashing following application, or touching lesions to prevent spread to others or to other areas of the body.
- Advise patient to begin application of docosanol at the first sign of a sore or blister, even during prodromal stage (feeling of burning, itching, tingling, or numbness).
- Inform patient that docosanol reduces duration of herpes simplex virus episodes but does not cure virus. Viral reactivation may be triggered by ultraviolet radiation or sun exposure, stress, fatigue, chilling, and windburn. Other possible triggers include fever, injury, menstruation, dental work, and infectious diseases (cold, flu).
- Advise patient to notify health care professional if lesions do not heal in 14 days or if fever, rash, or swollen lymph nodes occur.
- Reduction in duration of symptoms (pain, burning, itching, tingling) of herpes simplex virus episodes.
Drug Guide, © 2015 Farlex and Partners